Overview

Update
Total Equity Funding
$102.35M in 5 Rounds from 8 Investors
Most Recent Funding
$3.25M Venture on September 28, 2015
Headquarters:
Cranbury, NJ
Description:
VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus.
Founders:
Categories:
Health Care, Biotechnology, Health Diagnostics
Website:
http://www.vaxinnate.com
Social:

Funding Rounds (7) - $129.26M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2015$3.25M / Venture0
Oct, 2014$6M / Venture1
Jan, 2014$2.1M / Grant0
Feb, 2012$24.81M / Debt Financing0
Jun, 2009$30M / Series D7
Oct, 2006$40M / Series C6
Mar, 2004$23.1M / Series B4

Current Team (4)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    3 Cedar Brook Drive

    Suite #1

    Cranbury, NJ

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos